21% Holder Oregon Community Foundation Agrees to Sell Entire Stake at 40% Discount
JCTC has more than doubled off its 52-week low of $1.54.
Summary
Oregon Community Foundation, a 21.0% shareholder, has agreed to sell its entire stake in Jewett Cameron to Kotarba Partners Fund I, LP, with an initial tranche priced at $1.85 per share — a 40.5% discount to the current market price.
Key Events · Ownership and Investor Activity · JCTC
-
21% Holder Sells Entire Stake
Oregon Community Foundation has agreed to sell all 738,534 shares (21.0% of outstanding) to Kotarba Partners Fund I, LP, in a structured transaction.
-
Initial Purchase at Deep Discount
The buyer is obligated to purchase 176,006 shares at $1.85 per share by September 30, 2026 — a 40.5% discount to the current $3.11 market price.
-
Optional Remaining Purchases
The buyer has an option to purchase the remaining 562,528 shares by March 31, 2028, at 85% of the 30-day VWAP, with a floor of $1.85 and a cap of $4.00 per share.
-
Potential Overhang and Price Pressure
The sale of a 21% block at a steep discount could create a significant overhang on the stock, especially given the company's recent $6.0M quarterly loss and reduced credit line.
Analysis · JCTC · Trade & Services
Oregon Community Foundation, holding 21.0% of Jewett Cameron, has entered into a purchase agreement to sell its entire 738,534-share position to Kotarba Partners Fund I, LP. The initial mandatory purchase of 176,006 shares is priced at $1.85 per share — a 40.5% discount to the current $3.11 market price — with an option for the buyer to acquire the remaining shares at 85% of the 30-day VWAP (capped at $4.00) through March 2028. This block sale by a major shareholder at a deep discount signals a potential overhang and could pressure the stock, especially given the company's recent financial struggles and the ongoing activist campaign by AJB Capital.
At the time of this filing, JCTC was trading at $3.11 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $10.9M. The 52-week trading range was $1.54 to $4.02. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.